AzTrials
AzTrials

Data CollectionNCT04674371

German Point Prevalence Study on CVC

An observational study of Data Collection, run by Wolfram Schummer, MD, PhD at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It has now been 90 years since Werner Forssmann developed the CVC. Nowadays CVCs play an integral role for critically ill patients. Despite the high number of central venous access devices inserted annually, there are limited data on the incidence of the associated procedural complications, many of which carry… Read more about this study

Who is it for?
Any age
Conditions the study is for
Data Collection
What is being tested?
central venous catheter insertion
How many people
537 participants
Where
1 siteGermany
Study dates
17 May 2022to 20 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Over 2000 patients in Germany

Who may be able to join

  • Adults
  • Young Adults
  • Children
  • Infants
  • Neonates
  • Elective central venous access procedures
Show all 29Show fewer
  • Emergency central venous access procedures
  • Anesthesiologists
  • Internist
  • Neurologist
  • Surgeon
  • Etc.
  • Arterial cannulation/injury/cerebral embolization/hemorrhage
  • Catheter or wire shearing or loss
  • Lacerations of great vessels
  • Exsanguination
  • Hemo/pneumothorax; peritoneal hemorrhage
  • Pneumothorax
  • Tamponade
  • Tracheal injury
  • Air embolism
  • Heart puncture (tamponade)
  • Hemothorax
  • Stroke
  • Mortality
  • Number of attempts at central line placement
  • Failed insertion attempts
  • Successful, nontraumatic procedure
  • Wire, needle, catheter issues

Who cannot join

  • None
  • Procedures
  • None
  • Providers
  • None
  • Selection of catheter insertion site
Show all 13Show fewer
  • External jugular
  • Internal jugular
  • Subclavian
  • Femoral
  • Complications
  • Infections or other complications not associated with central venous catheterization
  • Mechanical injury or trauma not associated with central venous catheterization

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V.

    Mitte, 10117

Other trials in Germany

About this study

Official title: German Point Prevalence Study on Central Venous Catheter

It has now been 90 years since Werner Forssmann developed the CVC. Nowadays CVCs play an integral role for critically ill patients.

Despite the high number of central venous access devices inserted annually, there are limited data on the incidence of the associated procedural complications, many of which carry substantial clinical risk. This point was highlighted in recently published Association of Anaesthetists of Great Britain and Ireland "Safe vascular access 2016" guidelines and "Clinical guidelines on central venous catheterisation" in 2014 of the Swedish Society of Anaesthesiology and Intensive Care Medicine.

Read more

This German point prevalence study should identify the number of central venous catheter insertions and the incidence of various and especially serious mechanical complications across multiple hospital sites within one day.

Secondary aims are to identify the availability of resources and infrastructure to facilitate safe central venous catheter insertion and management of potential complications.

As much hospital sites as possible should participate and identify all adult central venous catheter insertions, with subsequent review of any complications detected.

Additionally, resources while inserting the CVC should be specified such as ultrasound for assessment of ultrasound anatomy and/or ultrasound-guidance. Furthermore, assessment of the CVC tip should be studied whether done during CVC placement with

  • ECG-guidance or by
  • transthoracic/transesophageal ultrasound with the Microbubble test or more conventional post hoc with
  • bedside chest X-ray Any mechanical complication should be documented untill day three post insertion. The background is to identify possible perforations due to initially unfavorable CVC tip positions (angle > 40 ° to wall of the superior vena cava).

Participation in the study is open to all disciplines (anesthesia, intensive care, internal medicine, surgery, etc.) that regularly perform CVCs.

Read the detailed description

Questions

  • How experienced are the CVC operators?
  • What are the demographics of the patients included?
  • How many emergency patients will be included in the study?
  • How is the distribution of the punctured vessels and that of the respective sides?
  • How many puncture attempts are necessary to achieve a successful CVC placement and how often do problems with the Seldinger-wire occur?
  • How often is ultrasound used to place a CVC and if so,
  1. Only for Screening?
  2. Puncture under ultrasound view?
  • What is the distribution between short and long axis view?
  • What catheter types and which caliber in French are being inserted?
  • Catheter position control:
  1. by EKG-lead on Pmax or Pmax - x cm (withdroth)
  2. by means of transthoracic ultrasound and agitated NaCl solution
  3. by means of transesophageal echocardiography and NaCl solution
  4. by means of X-ray image
  5. other or missing position control
  • Statement on the position of the CVC tip
  • How common are CVC-malpositions and what is their distribution?
  • Which complications occur within 72 h? Which measures do you require and how do they affect the respective patient?
Conditions
Data Collection
Being tested
central venous catheter insertion
Keywords
Central venous catheter, central venous line, Catheterization, Central Venous / access, Catheterization, Central Venous / methods, Catheterization, Central Venous / instrumentation, Catheterization, Central Venous / adverse effects, Placement of larger catheters, Insertion of CVCs, Complication of CVCs, CVC misplacement, Ultrasonography, Interventional / adverse effects, Ultrasonography, Interventional / instrumentation, Ultrasonography, Interventional / methods, Electroctrocardiography, Radiography, Echocardiographie/ TEE, Vascular Access Devices / standards, Vascular Access Devices / trends, Critical Illness / therapy, Humans, Adults, Adolescents
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • central venous catheter insertionOther

    Every operator should perform the CVC Insertion Procedure according to his common clinical practice.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patients Demographics

    All patients with a CVC Insertion on May 17th. 2022 in participating Hospitals independent of sex, age or BMI in kg/m^2 are eligible

    Measured: 17.05.2022

  2. Complications and malpositions

    Which complications and malpositions occur within 72 h

    Measured: 17.05.2022-20.05.2022

Secondary outcomes (8)
  1. Percentage of the emergency procedure

    How many emergency patients will be included in the study

    Measured: 17.05.2022

  2. Distribution of the vessel sites und sides

    distribution of the punctured vessels (external jugular, internal jugular, subclavian, femoral

    ) and that of the respective sides

    Measured: 17.05.2022

  3. Experience of the operator

    Resident physician/ Specialist doctor

    Measured: 17.05.2022

  4. Puncture attempts

    How many puncture attempts are necessary to achieve a successful CVC

    Measured: 17.05.2022

  5. Type and caliber of catheter

    What catheter types and which caliber in French are being inserted

    Measured: 17.05.2022

  6. Wire problems/issues

    witch and how often do problems with the Seldinger-wire occur

    Measured: 17.05.2022

  7. Ultrasound assistance

    Screening / Online guidance / Short or long axis view

    Measured: 17.05.2022

  8. CVC tip position

    measures to ensure central venous catheter tip position (i.e. CXR, ECG method and ultrasound)

    Measured: 17.05.2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2020
  2. Study start17 May 2022
  3. Primary completion20 May 2022
  4. Study completion20 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
537 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04674371
Sponsor's protocol ID
DRKS00016855
Other IDs
U1111-1229-1554
Status last verified
May 2022
First submitted
13 Dec 2020
Last updated
10 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Schmidt GA, Blaivas M, Conrad SA, Corradi F, Koenig S, Lamperti M, Saugel B, Schummer W, Slama M. Ultrasound-guided vascular access in critical illness. Intensive Care Med. 2019 Apr;45(4):434-446. doi: 10.1007/s00134-019-05564-7. Epub 2019 Feb 18.

    PubMed 30778648
  • McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33. doi: 10.1056/NEJMra011883. No abstract available.

    PubMed 12646670
  • Schummer W, Sakka SG, Huttemann E, Reinhart K, Schummer C. [Ultrasound guidance for placement control of central venous catheterization. Survey of 802 anesthesia departments for 2007 in Germany]. Anaesthesist. 2009 Jul;58(7):677-85. doi: 10.1007/s00101-009-1569-1. German.

    PubMed 19547936
  • Frykholm P, Pikwer A, Hammarskjold F, Larsson AT, Lindgren S, Lindwall R, Taxbro K, Oberg F, Acosta S, Akeson J. Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2014 May;58(5):508-24. doi: 10.1111/aas.12295. Epub 2014 Mar 5.

    PubMed 24593804
  • Coe AJ. AAGBI Safe vascular access guidelines I. Anaesthesia. 2016 Aug;71(8):985. doi: 10.1111/anae.13553. No abstract available.

    PubMed 27396261
  • Bierman S. AAGBI safe vascular access guidelines II. Anaesthesia. 2016 Aug;71(8):985-6. doi: 10.1111/anae.13554. No abstract available.

    PubMed 27396262
  • Lathey RK, Jackson RE, Bodenham A, Harper D, Patle V; Anaesthetic Audit and Research Matrix of Yorkshire (AARMY). A multicentre snapshot study of the incidence of serious procedural complications secondary to central venous catheterisation. Anaesthesia. 2017 Mar;72(3):328-334. doi: 10.1111/anae.13774. Epub 2016 Dec 16.

    PubMed 27981565

Questions about this trial

What is this clinical trial studying?

An observational study of Data Collection, run by Wolfram Schummer, MD, PhD at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 29 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patients Demographics (time frame: 17.05.2022). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04674371, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2022; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in